IFCPE 2017

Prof Sacchini talks to ecancer at IFCPE 2017 about his involvement with breast conservation therapy and the progress made in recent years. Prof Sacchini goes on to discuss the considerations taken into account regarding the axillary lymph nodes when performing sentinel lymph node biopsy.

Prof Naredi talks to ecancer at IFCPE 2017 about the need to involve patients more throughout the care process in order to be able to create a more personalised agenda of care. Prof Naredi goes on to highlight the importance of institutions and organisations working together to develop essential requirements to be provided for patients.

Prof Casali talks to ecancer at IFCPE 2017 about the difficulties faced when attempting to provide personalised medicine for rare cancers.

Prof Selby talks to ecancer at IFCPE 2017 about bringing together patients and professionals to improve care through patient empowerment and patient centred care. There are some emerging themes about the shortfall of long term survival rate in Europe because of the ‘patchy’ nature of cancer care. Prof Selby believes that it's important to be systematic and share practice between countries and institutions in order to boost care and survival rates.

Silvia Fernández Martínez talks to ecancer at IFCPE 2017 about the issues faced by patients when attempting to returning to work. She discusses attempting to alter the interpretation of dismissal regulations and legislation in certain countries to safeguard patients from being dismissed from work due to reduced capacity or absence from work.

Prof Pravettoni talks with ecancer at IFCPE 2017 about the recent shift towards personalised medicine and patient empowerment through information, knowledge and decision making. Prof Pravettoni goes on to discuss research that shows that empowered patients quality of life is greatly improved compared to patients who have not been empowered throughout their care.

Prof Denis talks with ecancer at IFCPE 2017 about the European Prostate Cancer Coalition and their aim to support men with prostate cancer across Europe.

Prof Sobrero talks to ecancer at IFCPE 2017 about the way that ESMO manages and ranks the clinical benefits of new drugs in order to help with prescription. He goes on to talk about his paper that highlights some of the problems with the scale due to the narrow criteria observed when ranking new drugs.

Prof Kloss talks to ecancer at IFCPE 2017 about the need to highlight the rights of cancer patients in relation to work. She discusses her research into helping recovering patients get back into work as part of their care.

Prof de Braud talks to ecancer at IFCPE 2017 about the development of new drugs since 2013 and how these new drugs have improved patients care and quality of life.

Dr Pruneri talks to ecancer at IFCPE 2017 about treating the 20% of oestrogen-receptor positive breast cancer patients who relapse following first-line treatments. He describes how comparative genotyping of primary tumours and subsequent lesions could reveal treatment resistance, giving the example of recent research exposing aromatase inhibitor resistance.

Dr Nicholl talks to ecancer at IFCPE 2017 outlining the constantly updating guidelines for breast cancer screening and diagnosis. By updating practice and clinical guidelines regularly, Dr Nicholl highlights better quality assurance and closer personalisation of care, so that fewer patients fall between the cracks. These guidelines follow mapping of all breast cancer services in the EU to establish a scheme that fits a wide range of resource availability.

Dr Pruneri talks to ecancer at IFCPE 2017 about a clinical trial looking at the prevalence of the aromatase gene amplification.

Paola Kruger talks to ecancer at IFCPE 2017 about what patients can do to be more involved in their own therapy options and how the patients input can be valuable within a clinical trial. She discusses the importance of patients creating a community, allowing patients to connect, share information and support each other throughout their care.

Denis Horgan talks to ecancer at IFCPE 2017 about the European Alliance for Personalised Medicine and looking to integrate innovation into healthcare and patient empowerment. Denis goes on to discuss the guidelines outlined by the European Alliance for Personalised Medicine and how these guidelines can drive innovation into healthcare systems.